Balaxi Pharmaceuticals Ltd - BALAXI PHARMA Share Price

Sector: Trading | ISIN: INE618N01014
₹ 474.35 (-2.64%) icon11 Aug, 2023, 3:41:43 PM
Open
₹ 495.95
Prev. Close
₹ 487.20
Turnover(lac)
₹ 9.40
Day's High
₹ 495.95
Day's Low
₹ 470.05
52 Wk High
₹ 706.00
52 Wk Low
₹ 423.85
Book Value
₹ 85.11
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 485.27
P/E
34.65
EPS
13.69
Div. Yield
0.11

Balaxi Pharmaceuticals Ltd KEY RATIOS

sector: Trading

  • CMP

    as on 8/11/2023 3:41:43 PM

    ₹ 474.35 -12.85 -2.64
  • Open
  • ₹ 495.95
  • Prev. Close
  • ₹ 487.2
  • Turnover(Lac.)
  • ₹ 9
  • Day's High
  • ₹ 495.95
  • Day's Low
  • ₹ 470.05
  • 52 Week's High
  • ₹ 706
  • 52 Week's Low
  • ₹ 423.85
  • Book Value
  • ₹ 85.11
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 485.27
  • P/E
  • 34.65
  • EPS
  • 13.69
  • Divi. Yield
  • 0.11

Balaxi Pharmaceuticals Ltd Corporate Actions

27 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Jul , 2023

12:00 AM

22 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2023

12:00 AM

27 Oct , 2022

12:00 AM

27 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Sep , 2022

12:00 AM

30 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

Balaxi Pharmaceuticals Ltd News and Update

Image not found
  • 11 August, 2023 |
  • 7:25 PM

The third-largest polluter in the world, France, has decided to purchase a 25% share in Adani New Industries Ltd. for an unknown sum to support green hydrogen projects there.

Image not found
Article Image
  • IIFL News Service |
  • 10 August, 2023 |
  • 7:24 PM
Image not found
  • IIFL News Service |
  • 10 August, 2023 |
  • 7:24 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Balaxi Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
14 August , 2023 | 08:18 AM

PROMOTER - TOTAL71.22%

Indian: 71.22%

Foreign: 0%

NON-PROMOTER - TOTAL 28.78%

Institutions: 18.60%

Non-Institutions: 10.18%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Balaxi Pharmaceuticals Ltd FINANCIALS

Balaxi Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Balaxi Pharmaceuticals Ltd

  • Ashish Maheshwari
  • Managing Director
  • Minoshi Maheshwari
  • Executive Director
  • Kunal M Bhakta
  • Independent Director
  • Gandhi Gamji
  • Independent Director
  • M. Srinivas Rao
  • Independent Director
  • Chinta Shalini
  • Company Sec. & Compli. Officer
  • Purnima Singh Kamble
  • Independent Director

Summary

Balaxi Ventures Limited (erstwhile known as The Anandam Rubber Company Limited) is a public limited company incorporated in India in September 28, 1942 with a basic objective of running rubber and tea plantations and owns several plantations across South India. In the year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products Securities and Exchange Board of India (SEBI) vide Circular dated May 30, 2012 had issued revised Exit Policy for de-recognized/non-operational stock exchanges. Pursuant to the circular, Madras Stock Exchange has been de-recognized by SEBI, recently. Further, as per above cited circular issued by SEBI on May 30, 2012, and Public Notice issued by Madras Stock Exchange Limited (MSE), it cleared that the Exclusively Listed Companies, which fail to obtain listing on any other stock exchange, will cease to be a listed company and will be moved to the Dissemination Board by the exiting stock exchange. Also, it is to be noted that SEBI has given a time limit of eighteen months for getting listed with any of the recognized stock exchanges. In pursuance to the above notice, the company has submitted listing application with National Stock Exchange of India (NSE) Limited... Read More


Reports by Balaxi Pharmaceuticals Ltd


Reports by Balaxi Pharmaceuticals Ltd

Company FAQ

No Record Found